Rational Design of Peptide Inhibitors Targeting HSP90–CDC37 Protein–Protein Interaction-Reference-Cited by-同舟云学术

Rational Design of Peptide Inhibitors Targeting HSP90–CDC37 Protein–Protein Interaction

Published:2024-01 Issue:2 Volume:16 Page:125-138
ISSN:1756-8919
Container-title:Future Medicinal Chemistry
language:en
Short-container-title:Future Med. Chem.

Author:

Zhang Qiuyue¹²^ORCID,Yan Ling¹²,Zhang Yuxuan¹²,Zhang Lixiao¹²,Yu Jia¹²,You Qidong¹²^ORCID,Wang Lei¹²^ORCID

Affiliation:

1. State Key Laboratory of Natural Medicines & Jiangsu Key Laboratory of Drug Design & Optimization, China Pharmaceutical University, Nanjing, 210009, China

2. Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China

Funder

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

China Postdoctoral Science Foundation

the Fundamental Research Funds for the Central Universities

Jiangsu Funding Program for Excellent Postdoctoral Talent

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.4155/fmc-2023-0320

Reference55 articles.

1. Molecular chaperones in protein folding and proteostasis

2. Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy

3. Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90–Kinase Interactions

4. A global view of Hsp90 functions

5. HSP90 and the chaperoning of cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of new Hsp90–Cdc37 protein–protein interaction inhibitors: in silico screening and optimization of anticancer activity;RSC Advances;2024